These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 15856409

  • 1. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G, Donath F, Maurer A, Diefenbach K, Bauer S, Henneicke-von Zepelin HH, Friede M, Roots I.
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I.
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [Abstract] [Full Text] [Related]

  • 3. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC, Uehleke B, Woehling H, Petzsch M, Majcher-Peszynska J, Hehl EM, Sievers H, Frank B, Riethling AK, Drewelow B.
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [Abstract] [Full Text] [Related]

  • 4. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD.
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [Abstract] [Full Text] [Related]

  • 5. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF, Fitzgerald SM, Lagattuta TF, Hruska MW, Egorin MJ.
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [Abstract] [Full Text] [Related]

  • 6. The effects of St. John's wort extract and amitriptyline on autonomic responses of blood vessels and sweat glands in healthy volunteers.
    Siepmann M, Kirch W, Krause S, Joraschky P, Mueck-Weymann M.
    J Clin Psychopharmacol; 2004 Feb; 24(1):79-82. PubMed ID: 14709951
    [Abstract] [Full Text] [Related]

  • 7. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
    Hostanska K, Reichling J, Bommer S, Weber M, Saller R.
    Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
    Schempp CM, Winghofer B, Müller K, Schulte-Mönting J, Mannel M, Schöpf E, Simon JC.
    Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers.
    Burstein AH, Horton RL, Dunn T, Alfaro RM, Piscitelli SC, Theodore W.
    Clin Pharmacol Ther; 2000 Dec; 68(6):605-12. PubMed ID: 11180020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver.
    Dostalek M, Pistovcakova J, Jurica J, Tomandl J, Linhart I, Sulcová A, Hadasova E.
    Life Sci; 2005 Dec 05; 78(3):239-44. PubMed ID: 16125735
    [Abstract] [Full Text] [Related]

  • 12. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD.
    JAMA; 2003 Sep 17; 290(11):1500-4. PubMed ID: 13129991
    [Abstract] [Full Text] [Related]

  • 13. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.
    Müller T, Mannel M, Murck H, Rahlfs VW.
    Psychosom Med; 2004 Sep 17; 66(4):538-47. PubMed ID: 15272100
    [Abstract] [Full Text] [Related]

  • 14. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
    Mai I, Bauer S, Perloff ES, Johne A, Uehleke B, Frank B, Budde K, Roots I.
    Clin Pharmacol Ther; 2004 Oct 17; 76(4):330-40. PubMed ID: 15470332
    [Abstract] [Full Text] [Related]

  • 15. Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
    Adiwidjaja J, Boddy AV, McLachlan AJ.
    Clin Pharmacokinet; 2019 Jul 17; 58(7):911-926. PubMed ID: 30675694
    [Abstract] [Full Text] [Related]

  • 16. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C, Engman H, Knutson L, Hedeland M, Bondesson U, Lennernäs H.
    Clin Pharmacol Ther; 2004 Apr 17; 75(4):298-309. PubMed ID: 15060508
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M, Bekersky I, Blum RA, Tolbert D.
    Pharmacotherapy; 2012 Apr 17; 32(4):340-53. PubMed ID: 22422635
    [Abstract] [Full Text] [Related]

  • 18. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
    Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD.
    Clin Pharmacol Ther; 2004 Jan 17; 75(1):89-100. PubMed ID: 14749695
    [Abstract] [Full Text] [Related]

  • 19. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
    Barnes J, Barber N, Wheatley D, Williamson EM.
    Planta Med; 2006 Mar 17; 72(4):378-82. PubMed ID: 16557483
    [Abstract] [Full Text] [Related]

  • 20. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?
    Beattie PE, Dawe RS, Traynor NJ, Woods JA, Ferguson J, Ibbotson SH.
    Br J Dermatol; 2005 Dec 17; 153(6):1187-91. PubMed ID: 16307656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.